These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29189562)

  • 21. Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody.
    Ogawa J; Harigai M; Akashi T; Nagasaka K; Suzuki F; Tominaga S; Miyasaka N
    Ann Rheum Dis; 2006 Dec; 65(12):1667-9. PubMed ID: 17105857
    [No Abstract]   [Full Text] [Related]  

  • 22. Immediate reduction of white blood cell count after tocilizumab administration was observed in some cases.
    Nagamine R; Chen W; Hara T; Kondo K; Sugioka Y
    Mod Rheumatol; 2009; 19(3):348-50. PubMed ID: 19288171
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tocilizumab as monotherapy is clinically more effective than adalimumab].
    Kreutzkamp B
    Med Monatsschr Pharm; 2013 Sep; 36(9):356-7. PubMed ID: 24069651
    [No Abstract]   [Full Text] [Related]  

  • 24. MS arising during Tocilizumab therapy for rheumatoid arthritis.
    Beauchemin P; Carruthers R
    Mult Scler; 2016 Feb; 22(2):254-6. PubMed ID: 26743640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumonia with an unusual outcome in an immunocompetent patient.
    Sánchez-Jareño M; Martínez Verdasco A; Esteban Rodriguez I; Álvarez-Sala R
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(6):382-383. PubMed ID: 28238503
    [No Abstract]   [Full Text] [Related]  

  • 26. Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA).
    Kobayashi K; Okamoto Y; Inoue H; Usui T; Ihara M; Kawamata J; Miki Y; Mimori T; Tomimoto H; Takahashi R
    Intern Med; 2009; 48(15):1307-9. PubMed ID: 19652436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pasteurella multocida empyema in a patient after mitral valve replacement secondary to endocarditis].
    Abad C; Cáceres JJ; Ferrer JM; González L; Alvarez F; Bordes A
    An Med Interna; 2003 Aug; 20(8):441-2. PubMed ID: 14516272
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.
    Younis S; Rimar D; Slobodin G; Rosner I
    J Rheumatol; 2012 Oct; 39(10):2055-6. PubMed ID: 23028035
    [No Abstract]   [Full Text] [Related]  

  • 29. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
    Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
    Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    McLaughlin M; Östör A
    Expert Opin Drug Saf; 2015 Mar; 14(3):429-37. PubMed ID: 25553607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report 1: A case of failed posaconazole prophylaxis.
    Maertens J; Cuppens K; Schoemans H
    Mycoses; 2010 Jul; 53 Suppl 2():3-5. PubMed ID: 20591011
    [No Abstract]   [Full Text] [Related]  

  • 32. Case report 2: Fungal infections in chronic obstructive pulmonary disease.
    Meersseman W
    Mycoses; 2010 Jul; 53 Suppl 2():6-7. PubMed ID: 20591012
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pasteurella multocida septic arthritis in total knee prosthesis: report of a case].
    Kouevidjin BT; Bassinga JS
    Pan Afr Med J; 2015; 20():366. PubMed ID: 26523162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corneal ulcer secondary to Pasteurella multocida and Klebsiella oxytoca in a 79-year-old patient with dysthyroid orbitopathy].
    Cornée C; Mainguy A; Coeuru D; Routier M; Lebranchu P; Vabres B
    J Fr Ophtalmol; 2020 Sep; 43(7):e245-e246. PubMed ID: 32564980
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
    Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
    Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)].
    Nasonov EL
    Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-acquired pneumonia due to Pasteurella multocida.
    Marinella MA
    Respir Care; 2004 Dec; 49(12):1528-9. PubMed ID: 15571646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal acquired hemophilia A in a patient with rheumatoid arthritis treated with adalimumab.
    Arthanari S; Ahmad H; Nisar M
    J Clin Rheumatol; 2012 Jan; 18(1):50-1. PubMed ID: 22157274
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of infections in rheumatoid arthritis patients treated with tocilizumab.
    Lang VR; Englbrecht M; Rech J; Nüsslein H; Manger K; Schuch F; Tony HP; Fleck M; Manger B; Schett G; Zwerina J
    Rheumatology (Oxford); 2012 May; 51(5):852-7. PubMed ID: 21865281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.
    Honda H; Kida H; Yoshida M; Tomita T; Fujii M; Ihara S; Goya S; Tachibana I; Kawase I
    Mod Rheumatol; 2011 Dec; 21(6):660-4. PubMed ID: 21472474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.